About TherDose
TherDose is a company based in Hyderabad (India) founded in 2003. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. TherDose has raised $3.98 million across 1 funding round from investors including Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust. The company has 137 employees as of April 06, 2024. TherDose offers products and services including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.
- Headquarter Hyderabad, India
- Employees 137 as on 06 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Therdose Pharma Pvt. Ltd.
- Date of Incorporation 19 Dec, 2003
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$3.32 M (USD)-16.17as on Mar 31, 2023
-
Net Profit
$76.14 K (USD)-93.73as on Mar 31, 2023
-
EBITDA
$472.24 K (USD)-69.24as on Mar 31, 2023
-
Total Equity Funding
$3.98 M (USD)
in 1 rounds
-
Latest Funding Round
$3.98 M (USD), Series A
Sep 28, 2016
-
Investors
Hitha Palepu Irrevocable Stock Trust
& 1 more
-
Employee Count
137
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TherDose
TherDose offers a comprehensive portfolio of products and services, including Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.
Chemotherapy medicines are developed for oncology treatment needs.
Generic drugs are produced for various therapeutic areas.
Specialty drugs are created for specific oncology requirements.
People of TherDose
Unlock access to complete
Funding Insights of TherDose
TherDose has successfully raised a total of $3.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.98 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TherDose
TherDose has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Hitha Palepu Irrevocable Stock Trust and Robert Pragada Irrevocable Stock Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for TherDose
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TherDose
Investment portfolio details for TherDose
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TherDose
Detailed financials for TherDose
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Therdose Comparisons
Peer comparison for TherDose
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TherDose
Detailed competitors of TherDose
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Therdose
Complete news archive for TherDose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TherDose
TherDose was founded in 2003 and raised its 1st funding round 13 years after it was founded.
TherDose is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
TherDose is a funded company, having raised a total of $3.98M across 1 funding round to date.
As of Apr 06, 2024, the latest employee count at TherDose is 137.
Annual revenue of TherDose is $3.32M as on Mar 31, 2023.
TherDose Pharma Pvt. Ltd. is engaged in the development and delivery of world-class chemotherapy medicines and generics, with a specialization in oncology. The company operates across various therapeutic areas, utilizing rigorous scientific principles through strong in-house research and development. Solutions are provided to diversified global markets, with over 35 generics and specialty drugs developed, alongside numerous dossiers filed in emerging markets. The commitment to affordable pricing is maintained to enhance accessibility to critical treatments.
TherDose offers Chemotherapy Medicines, Generic Drugs, and Specialty Drugs.
TherDose has 2 investors. Key investors include Hitha Palepu Irrevocable Stock Trust, and Robert Pragada Irrevocable Stock Trust.
The valuation of TherDose is $9.98M as of Sep 2016.